27500809|t|The nanocomposite nature of bone drives its strength and damage resistance
27500809|a|In human bone, an amorphous mineral serves as a precursor to the formation of a highly substituted nanocrystalline apatite. However, the precise role of this amorphous mineral remains unknown. Here, we show by using transmission electron microscopy that 100-300 nm amorphous calcium phosphate regions are present in the disordered phase of trabecular bone. Nanomechanical experiments on cylindrical samples, with diameters between 250 nm and 3,000 nm, of the bone's ordered and disordered phases revealed a transition from plastic deformation to brittle failure and at least a factor-of-2 higher strength in the smaller samples. We postulate that this transition in failure mechanism is caused by the suppression of extrafibrillar shearing in the smaller samples, and that the emergent smaller -is- stronger size effect is related to the sample-size scaling of the distribution of flaws. Our findings should help in the understanding of the multi-scale nature of bone and provide insights into the biomineralization process.
27500809	4	17	nanocomposite	T080	C0205199
27500809	28	32	bone	T023	C0262950
27500809	44	52	strength	T081	C0237897
27500809	57	63	damage	T169	C1883709
27500809	64	74	resistance	T169	C4281815
27500809	78	88	human bone	T023	C0277764
27500809	93	102	amorphous	T080	C1979848
27500809	103	110	mineral	T197	C0026162
27500809	123	132	precursor	T078	C1709634
27500809	140	149	formation	T169	C1522492
27500809	174	189	nanocrystalline	T073	C1721058
27500809	190	197	apatite	T197	C0003522
27500809	233	242	amorphous	T080	C1979848
27500809	243	250	mineral	T197	C0026162
27500809	291	323	transmission electron microscopy	T059	C0678118
27500809	340	349	amorphous	T080	C1979848
27500809	350	367	calcium phosphate	T121,T197	C0006711
27500809	368	375	regions	T029	C0005898
27500809	395	411	disordered phase	T082	C1254362
27500809	415	430	trabecular bone	T024	C0222660
27500809	432	458	Nanomechanical experiments	T062	C0681814
27500809	462	473	cylindrical	T082	C0946010
27500809	474	481	samples	T167	C0370003
27500809	488	497	diameters	T081	C1301886
27500809	534	540	bone's	T023	C0262950
27500809	541	548	ordered	T082	C1254362
27500809	553	570	disordered phases	T082	C1254362
27500809	582	592	transition	T052	C2700061
27500809	598	605	plastic	T070	C0678558
27500809	606	617	deformation	T033	C0575133
27500809	621	628	brittle	T033	C3810845
27500809	629	636	failure	T037	C0016658
27500809	671	679	strength	T081	C0237897
27500809	687	694	smaller	T080	C0547044
27500809	695	702	samples	T167	C0370003
27500809	727	737	transition	T052	C2700061
27500809	741	748	failure	T169	C0231174
27500809	749	758	mechanism	T169	C0441712
27500809	776	787	suppression	T169	C1260953
27500809	791	805	extrafibrillar	T026	C0225328
27500809	806	814	shearing	T061	C0205013
27500809	830	837	samples	T167	C0370003
27500809	861	868	smaller	T080	C0547044
27500809	874	882	stronger	T080	C0442821
27500809	883	894	size effect	T081	C0814843
27500809	913	924	sample-size	T081	C0242618
27500809	925	932	scaling	T052	C1947916
27500809	967	975	findings	T033	C0243095
27500809	1016	1034	multi-scale nature	T078	C0349590
27500809	1038	1042	bone	T023	C0262950
27500809	1073	1090	biomineralization	T042	C0006660
27500809	1091	1098	process	T067	C1522240